BASF Taps Geopolitical Windfall and €5.8bn Coatings Payday as Chemical Sector Drags

EU clears BASF's €7.7B coatings sale to Carlyle, requiring Nouryon polysulfide divestiture. Hormuz blockade bolsters BASF's logistics edge. Shares up slightly.

The blockaded Strait of Hormuz is proving an unlikely ally for BASF. With Asian chemical producers scrambling to reroute supplies past a bottleneck that normally handles a fifth of global oil and gas output, the German giant is keeping its own delivery chains intact across Europe. That logistical edge has given its shares a short-term lift, even as the broader industry confronts a deepening structural slump.

The Verband der Chemischen Industrie warned this week that production in Germany's chemical-pharmaceutical sector fell 2.8% in the first quarter of 2026 from the previous three months, with capacity utilisation languishing at 75.1% — well below the level needed for healthy margins. BASF itself has been grappling with currency headwinds and volatile raw material costs, as CFO Dirk Elvermann recently flagged. The company is lean on overheads: its "CoreShift" efficiency programme, steered by Julia Raquet, targets a 20% cut in cash fixed costs by 2029 against the 2024 baseline.

Yet the immediate market attention has been on a deal that promises a substantial capital injection. The European Commission on 2 June cleared the sale of BASF's coatings business to private equity firm Carlyle — but with strings attached. The transaction, originally agreed in October 2025, carries an enterprise value of €7.7 billion for the automotive OEM, refinish and surface treatment units. BASF will retain a 40% stake in the coatings division after closing and expects a pre-tax cash inflow of roughly €5.8 billion.

Brussels identified a vertical competition risk because Carlyle already owns specialty chemicals maker Nouryon, which is one of only two global producers of polysulfides — a key ingredient for sealants in aerospace. BASF Coatings also offers products in that niche. To prevent rivals from being locked out of a hard-to-replace input, the Commission ordered Carlyle to divest Nouryon's entire polysulfide business, including its plant in Greiz, Thuringia, along with the related licences, contracts and staff. Any buyer must demonstrate either chemical industry expertise or experience as a financial investor with chemicals holdings. The EU will vet the purchaser in a separate process, and an independent trustee will monitor compliance.

Closing was originally pencilled in for the second quarter of 2026, with the EU clearance being the last major regulatory hurdle. But the deal will not be consummated until Carlyle finds an acceptable buyer for the Nouryon polysulfide assets. For BASF, the approval is still a critical milestone: the proceeds are earmarked to shore up the balance sheet and boost capital returns as the group reshapes its portfolio.

Investor reaction has been measured. On the day of the Commission's decision, BASF shares edged up 0.30% to €50.69. Later in the same week, as the Hormuz disruption story gained traction, the stock added another 1.39% to reach €51.24. Year-to-date, gains have ranged between 13.3% and 14.5% depending on the reporting date, comfortably above the 200-day moving average of €46.79. The 52-week high of €55.05, set in April, remains about 7% out of reach — a gap that may narrow or widen depending on how swiftly Carlyle can execute the required divestiture and unlock the €5.8 billion payment.